Investing
Cathie Wood's ARK Invest Sells Nearly 850,000 Shares of Takeda Pharma

Published:
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold nearly 850,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Tuesday, as the share price of this fund traded was up 7% in the day’s session. Its share price is still negative over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 846,189 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $11.7 million. This is only a small fraction of the total holdings. This fund is down 32% over the past 52 weeks.
Here is a quick look at all the trades that took place across all ARK ETFs:
Fund | Direction | Ticker | Name | Shares |
---|---|---|---|---|
ARKF | Buy | DSYSJ | DISCOVERY | 55,621 |
ARKG | Buy | SGFY | SIGNIFY HEALTH | 160,234 |
ARKG | Sell | TAK | TAKEDA PHARMACEUTICAL | 846,189 |
ARKK | Buy | SGFY | SIGNIFY HEALTH | 313,766 |
ARKK | Buy | TDOC | TELADOC HEALTH | 63,567 |
ARKK | Sell | EDIT | EDITAS MEDICINE | 138,796 |
ARKQ | Buy | BLDE | BLADE AIR MOBILITY | 11,926 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
It’s hard to believe, but today there are credit cards offering up to 5% cash back (you read that right) on some items, $200 statement credits, $0 annual fees, travel rewards, and more. See for yourself, we’ve assembled a list of the top credit cards today right here.
Frankly, with rewards this good we don’t expect them to be available forever. But if you sign up today you can secure some of the best rewards we’ve ever seen. Click here to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.